Abstract
The synthesis of new triphenyltin derivatives with (N-substituted-pyrazol-3-yl) carboxylic acid fragments is described. The in vitro antibacterial activity of the new agents was evaluated against two fungal strains (Saccharomyces cerevisiae and Fusarium oxysporum f.sp albedinis) and against bacterial strains (Echerichia coli). A considerable activity was recorded with respect to the three studied micro-organisms. Structure activity relationship studies (SAR) reflect the effect of substituted pyrazolic fragment.
Keywords: Pyrazolic acids, Triphenyltin derivatives, Biological activities
Letters in Drug Design & Discovery
Title: Synthesis and Biological Activities of New Triphenyl Organotin (IV) Based on the Pyrazole Carboxylic Acids
Volume: 4 Issue: 5
Author(s): Abderrahmane Yahyi, Abdelkader Ettouhami, Smaail Radi, Ismail Zidane, Abdelkader Hakkou and Mohamed Bouakka
Affiliation:
Keywords: Pyrazolic acids, Triphenyltin derivatives, Biological activities
Abstract: The synthesis of new triphenyltin derivatives with (N-substituted-pyrazol-3-yl) carboxylic acid fragments is described. The in vitro antibacterial activity of the new agents was evaluated against two fungal strains (Saccharomyces cerevisiae and Fusarium oxysporum f.sp albedinis) and against bacterial strains (Echerichia coli). A considerable activity was recorded with respect to the three studied micro-organisms. Structure activity relationship studies (SAR) reflect the effect of substituted pyrazolic fragment.
Export Options
About this article
Cite this article as:
Yahyi Abderrahmane, Ettouhami Abdelkader, Radi Smaail, Zidane Ismail, Hakkou Abdelkader and Bouakka Mohamed, Synthesis and Biological Activities of New Triphenyl Organotin (IV) Based on the Pyrazole Carboxylic Acids, Letters in Drug Design & Discovery 2007; 4 (5) . https://dx.doi.org/10.2174/157018007780867889
DOI https://dx.doi.org/10.2174/157018007780867889 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Catatonia, Malignant Catatonia, and Neuroleptic Malignant Syndrome
Current Psychiatry Reviews Determining Partition Coefficient (Log P), Distribution Coefficient (Log D) and Ionization Constant (pKa) in Early Drug Discovery
Combinatorial Chemistry & High Throughput Screening Glycosomal Targets for Anti-Trypanosomatid Drug Discovery
Current Medicinal Chemistry Gene Therapy for Familial Hypercholesterolemia
Current Pharmaceutical Design A Systematic Review on Curcumin and Anti-<i>Plasmodium berghei</i> Effects
Current Drug Discovery Technologies Estrogen Receptor Alpha: Impact of Ligands on Intracellular Shuttling and Turnover Rate in Breast Cancer Cells
Current Cancer Drug Targets Editorial [Extravascular Lung Water Measurements: Dont Jump Off the Bandwagon Yet! ]
Current Respiratory Medicine Reviews Activity Based Chemical Proteomics: Profiling Proteases as Drug Targets
Current Drug Discovery Technologies Non-Peptidic GnRH Receptor Antagonists
Current Medicinal Chemistry Thermodynamic and Kinetic Destabilization of Triosephosphate Isomerase Resulting from the Mutation of Conserved and Non-conserved Cysteines
Protein & Peptide Letters Natural Product-Based Antibiotics: Synthesis and SAR-Studies.
Current Pharmaceutical Design Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part-I)
Current Pharmaceutical Design Management of COVID-19 - A Review
Anti-Infective Agents High Mutation Rate Leads to Fitness Loss for Coronavirus Quasispecies
Coronaviruses Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic
CNS & Neurological Disorders - Drug Targets Pharmacological Management of PDA: Oral Versus Intravenous Medications
Current Clinical Pharmacology The Metabolic Treatment of Patients with Coronary Artery Disease: Effects on Quality of Life and Effort Angina
Current Pharmaceutical Design In Silico Drug Discovery Approaches on Grid Computing Infrastructures
Current Clinical Pharmacology Chitosan Oligomer and Zinc Oxide Nanoparticles for Treating Wastewaters: US20190134086 Patent Evaluation
Recent Patents on Biotechnology Relationship Between Carbapenems Structure and Minimal Inhibitory Concentration Selected Bacterial Strains
Letters in Drug Design & Discovery